IRTC240920C70000
- 6.40
- +0.40+6.67%
iRhythm Technologies Newsroom
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $120
Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $145
Oppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)
IRhythm Technologies Analyst Ratings
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $110
Wells Fargo Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $110
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and Irhythm Technologies (IRTC)
Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Oncolytics Biotech (ONCY) and Irhythm Technologies (IRTC)
Irhythm Technologies (IRTC) Receives a Buy From Wells Fargo
JP Morgan Maintains Overweight on IRhythm Technologies, Lowers Price Target to $100
J.P. Morgan Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $100
Baird Maintains Outperform on IRhythm Technologies, Lowers Price Target to $110
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $120
Oppenheimer Adjusts IRhythm Technologies Price Target to $145 From $165, Maintains Outperform Rating
A Quick Look at Today's Ratings for IRhythm Technologies(IRTC.US), With a Forecast Between $110 to $145
Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Cigna (CI)
Irhythm Technologies (IRTC) Gets a Buy From Truist Financial
IRhythm Technologies Analyst Ratings
Irhythm Technologies: Strong Buy Rating Amidst Surging Revenue and Management Confidence
IRhythm Technologies Analyst Ratings